Please assess the completion status of the following clinical trial:

Trial Title: Comparing the Efficacy of Methylphenidate, Dextroamphetamine and Placebo in Children Diagnosed With ADHD

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Age from 9.0 to 14.0.~* ADHD diagnosis following assessment at a child \& adolescent outpatient clinic.~* Clarification for stimulant treatment.~Exclusion Criteria:~* Moderate or severe mental retardation.~* Psychosis.~* Proven brain damage.~* Sensory deficits and/or motor impairments that make the individual in question unsuitable for the relevant tests.~* Epilepsy.~* The child has previously been prescribed stimulant medication or is being treated with such medication.~* The child commutes between parents or there are other factors that substantially reduce the possibility of obtaining reliable observations from parents (The child needs to live in one place through out the whole trial since otherwise might severely influence the child's behaviour and the observations).

- Gender: ALL
- Minimum Age: 9 Years
- Maximum Age: 14 Years
- Healthy Volunteers: f

Study Arms:
- Methylphenidate, Dexamphetamine, Placebo (Type: EXPERIMENTAL): The 36 participants received each of the three medications for two weeks. Six different medication sequences are possible. The participants are randomly chosen for each of the six sequences in a way that allow six participants into each of the six sequences to balance the sequences.

Based on this trial design, predict the completion outcome and termination type (if applicable).